Products

What will AGI do for Bemesetron?

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C15H17Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O98T3677PA, chemically known as 3-tropanyl-3,5-dichlorobenzoate but generally known as bemesetron, which bears US NIH Compound Identifier 1683. European Medicines Agency schedules Bemesetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05692MIG. The term BEMESETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). BEMESETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bemesetron under HS 29399900 and SITC 54149. As of Q4 2014, BEMESETRON remains the US FDA Preferred Term for this commodity. Bemesetron bears US NLM identifiers UMLS ID C0164151 and NCI Concept Code C80766. SMILES: CLC1CC(C(=O)OC2CC3N(C(CC3)C2)C)CC(CL)C1.